While research has revealed that children and adults hospitalized with COVID-19 are more susceptible to developing long COVID symptoms, a new study by researchers at UTHealth Houston found that children infected with COVID-19, but not hospitalized, still experienced long COVID symptoms up to three months past infection.
The study was published in The Pediatric Infectious Disease Journal.
Adults infected with COVID-19 develop circulating antibodies that last for nearly 500 days, according to a new study led by researchers at UTHealth School of Public Health.
The findings were published in The Journal of Infectious Diseases.
Children previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at UTHealth Houston.
A one-year, $10.3 million dollar grant from the U.S. Health Resources and Services Administration (HRSA) was awarded to increase COVID-19 vaccinations through the development and mobilization of existing community-based health and outreach workforces in the state by The University of Texas Health Science Center at Houston (UTHealth Houston).
October 4, 2022
A method that combines case investigation data from local health departments and hospitalizations records from local institutions allows for the objective detection of new waves of infection during a pandemic, according to research from UTHealth Houston.
August 8, 2022
While research has revealed that children and adults hospitalized with COVID-19 are more susceptible to developing long COVID symptoms, a new study by researchers at UTHealth Houston found that children infected with COVID-19, but not hospitalized, still experienced long COVID symptoms up to three months past infection.
The study was published in The Pediatric Infectious Disease Journal.
May 31, 2022
Adults infected with COVID-19 develop circulating antibodies that last for nearly 500 days, according to a new study led by researchers at UTHealth School of Public Health.
The findings were published in The Journal of Infectious Diseases.
March 18, 2022
Children previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at UTHealth Houston.
January 31, 2022
A one-year, $10.3 million dollar grant from the U.S. Health Resources and Services Administration (HRSA) was awarded to increase COVID-19 vaccinations through the development and mobilization of existing community-based health and outreach workforces in the state by The University of Texas Health Science Center at Houston (UTHealth Houston).
December 15, 2021
A nationwide effort to adequately vaccinate 8 in 10 adolescents against the human papillomavirus (HPV) could prevent 934,000 cases of virus-associated, male oropharyngeal cancer over this century, reported investigators at The University of Texas Health Science Center at Houston (UTHealth Houston) School of Public Health in The Lancet Regional Health—Americas.
December 9, 2021
Earlier this year, the UTHealth Center for Health Promotion and Prevention Research (CHPPR) launched Take Care, Texas, an online resource for up-to-date information on COVID-19 testing in Texas. Take Care, Texas is a part of the Rapid Acceleration of Diagnostics for Underserved Populations (RADxUP) program, which aims to develop an adaptive intervention to increase COVID-19 testing in vulnerable communities.
August 3, 2021
The Center for Health Promotion and Prevention Research (CHPPR) recently received $500,000 from the CDC to investigate solutions that will increase confidence in COVID-19 vaccines and ultimately increase uptake.
January 25, 2021
In one of the Houston neighborhoods hit hardest by the coronavirus, state and local public officials, together with leaders from The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas System, gathered at UT Physicians Multispecialty-Jensen on Saturday, Jan. 23, to encourage everyone to roll up their sleeves and receive the COVID-19 vaccine.
December 14, 2020
Binge drinkers increased their alcohol consumption by nearly 20% during COVID-19 stay-at-home orders, according to new research by public health experts at The University of Texas Health Science Center at Houston (UTHealth). Their study, published in the American Journal of Drug and Alcohol Abuse, is one of the first to analyze the association of stress caused by the pandemic and dangerous alcohol consumption.
